Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Morgan Stanley analyst Craig Hettenbach maintains Definitive Healthcare (NASDAQ:DH) with a Equal-Weight and lowers the price target from $2.5 to $1.5.
Morgan Stanley analyst Craig Hettenbach maintains Definitive Healthcare (NASDAQ:DH) with a Equal-Weight and lowers the price target from $2.5 to $1.5.